Optimization of Nanostructured Lipid Carriers of Fenofibrate Using a Box-Behnken Design for Oral Bioavailability Enhancement

CONCLUSION: A Box-Behnken design was successfully applied to optimize FNB-NLC formulation for the enhancement of the dissolution and bioavailability of FNB, a poorly water-soluble drug.PMID:33902411 | DOI:10.2174/1567201818666210423110745

Source: Current Drug Delivery - April 27, 2021 Category: Drugs & Pharmacology Authors: Huijuan Wang Wei Hong Xiangyu Li Qian Jin Weifeng Yea Yumiao Feng Biyao Huang Zhongjia Tai Lu Chen Zhiping Li Yuli Wang Yang Yang Chunsheng Gao Wei Gong Meiyan Yang Source Type: research